[ SPEQ LISTEN ]
Conversations from the people building, regulating, studying, and operating life sciences—placed in context so you can choose what is worth your time.
Curated by SPEQ; produced by the publishers shown. Inclusion is not endorsement of every claim or episode.
One player loads only after you ask for it—no autoplay and no wall of embedded players.
By ISPE
Conversations about pharmaceutical engineering, manufacturing, facilities, and emerging practice.
Connects technical standards and operational delivery to the people applying them in facilities.
By Qualistery
Practitioner conversations on pharmaceutical quality, validation, audits, and GMP execution.
Makes quality work concrete through practitioner experience rather than treating GMP as document recall.
By SOLABS
Discussions at the intersection of quality management, digital systems, people, and regulated operations.
Shows how quality-system design changes when workflows, training, and records become digital.
By Life Science Connect
Biotech leaders discuss company building, development strategy, manufacturing, financing, and growth.
Adds the operating and financing context that determines whether scientific programs can reach patients.
By Greenlight Guru
Medical-device quality and regulatory conversations spanning product development and post-market work.
Prevents the library from collapsing GxP into pharma and gives device professionals a dedicated signal.
By Uppsala Monitoring Centre
Global pharmacovigilance conversations about detecting, understanding, and communicating medicine safety.
Brings the post-market safety system and its public-health purpose into the broader lifecycle view.
By NIH Pragmatic Trials Collaboratory
Researchers examine the design, conduct, and real-world implementation of pragmatic clinical trials.
Connects GCP concepts to study design and operational choices without reducing clinical work to compliance.
By Biotech 2050
Long-horizon conversations with biotech leaders about science, company formation, capital, and the future of health.
Pairs technical innovation with the strategic decisions required to build and sustain a life-sciences company.
By Biotech Hangout
A panel-style discussion of current biotech business, policy, financing, and scientific news.
Offers a recurring cross-functional view of the forces shaping biotech decisions beyond a single specialty.
By Timmerman Report
In-depth interviews with biotech leaders about scientific ambition, company building, and durable leadership.
Provides the long-form leadership context that short news cycles usually omit.
By STAT
Reporting and analysis on biotech, drug development, policy, markets, and the people shaping the sector.
Supplies a current industry-news lens while keeping reported journalism distinct from SPEQ guidance.
By LogiPharma / WBR
Life-sciences supply-chain leaders discuss resilience, logistics, digital transformation, and operations.
Extends the library through distribution and supply—the lifecycle after release that often disappears from product stories.
By Association of Clinical Research Organizations
Clinical research leaders on trial conduct, regulation, technology, and the operating reality of running studies.
Speaks for the organizations that actually run trials, so GCP arrives as delivery constraints rather than as clauses to recite.
By The FDA Group
Regulatory, quality and clinical news read through what it changes for the teams who have to comply with it.
One of the few shows that covers RA, QA and clinical together, which is how a small quality function actually experiences them.
By Xtalks
Editorial conversations spanning pharma, biotech, medtech and food — drug development, regulation, trials and industry news.
Crosses the industry boundaries most shows stay inside, which is the same multi-industry span the rest of SPEQ is organised around.
By BioPhorum
Biopharmaceutical practitioners on manufacturing, digitalisation, knowledge management, raw materials and supply.
Reports what a cross-company collaboration actually agreed, which is closer to emerging practice than any single firm can speak to.
By Food Safety Magazine
Food safety professionals on hazard control, audits, recalls, culture and regulatory expectations across the supply chain.
Closes a real gap: SPEQ covers 21 CFR 117 and Codex, and until now the library had no voice from the food side of GxP at all.
By European Food Safety Authority (EFSA)
EFSA scientists explain how food-safety risk assessment is actually done, and how its conclusions are reached.
A regulator explaining its own risk assessment in its own words — the rarest provenance here, and the hardest to get second-hand.
By AAMI
Sterile processing practice — reprocessing, instructions for use, chemical monitoring, and the AAMI standards behind them.
Follows a device past release into reprocessing, where ST79 and the IFU a manufacturer wrote are either usable or they are not.